# A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

> **NCT01674361** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 99 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Bitopertin
- **DRUG:** Placebo
- **DRUG:** SSRI

## Key facts

- **NCT ID:** NCT01674361
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-31
- **Primary completion:** 2015-04-30
- **Final completion:** 2015-04-30
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674361, "A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01674361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*